litlas
Log inCreate account

Justin Stebbing

Active 1995–2025

136
Papers
20,221
Citations
82
h-index
132
i10-index

Citations

Citations per year for Justin Stebbing1988: 2 citations1997: 1 citations1999: 2 citations2000: 4 citations2001: 10 citations2002: 13 citations2003: 11 citations2004: 35 citations2005: 46 citations2006: 43 citations2007: 33 citations2008: 62 citations2009: 47 citations2010: 92 citations2011: 74 citations2012: 74 citations2013: 101 citations2014: 109 citations2015: 106 citations2016: 133 citations2017: 144 citations2018: 144 citations2019: 522 citations2020: 1,456 citations2021: 1,185 citations2022: 729 citations2023: 425 citations2024: 881 citations2025: 595 citations2026: 16 citations1989–1996: no citations, so these years are not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,019 citing papers, 19.8% of this breakdownChina: 1,442 citing papers, 14.1% of this breakdownUnited Kingdom: 711 citing papers, 7% of this breakdownItaly: 662 citing papers, 6.5% of this breakdownGermany: 475 citing papers, 4.7% of this breakdownFrance: 385 citing papers, 3.8% of this breakdownIndia: 372 citing papers, 3.6% of this breakdownSpain: 309 citing papers, 3% of this breakdownCanada: 247 citing papers, 2.4% of this breakdownAustralia: 229 citing papers, 2.2% of this breakdownJapan: 211 citing papers, 2.1% of this breakdownNetherlands: 207 citing papers, 2% of this breakdown
0%19.8%Other 28.8%

Institutions

Fields

  • Medicine57.5%
  • Biochemistry, Genetics and Molecular Biology32.6%
  • Immunology and Microbiology2.9%
  • Computer Science2.6%
  • Engineering0.8%
  • Mathematics0.6%
  • Other3%

Topics

  • COVID-19 Clinical Research Studies5%
  • Cancer Genomics and Diagnostics4.7%
  • Cancer Cells and Metastasis4.2%
  • SARS-CoV-2 and COVID-19 Research3.9%
  • MicroRNA in disease regulation3.2%
  • Long-Term Effects of COVID-192.2%
  • Other76.8%

Coauthors

All papers

Open in search
  1. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

    Authors: Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, Kenneth Chun-Yong Yap, William Jacot, Robert H. Jones, Huiyan Eng, Madhumathy G Nair, Pooyan Makvandi, Birgit Geoerger, Matthew H. Kulke, Richard D. Baird, Jyothi S. Prabhu, Daniela Carbone, Camilla Pecoraro, Daniel Boon Loong Teh, Gautam Sethi, Vincenzo Cavalieri, Kevin Lin, Nathalie Javidi‐Sharifi, Eneda Toska, Matthew S. Davids, Jennifer R. Brown, Patrizia Diana, Justin Stebbing, David A. Fruman, Alan Prem Kumar - Molecular Cancer 2023 cited by 1,908

  2. Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

    Authors: Raoul Charles Coombes, Karen Page, Raheleh Salari, Robert Hastings, Anne Armstrong, Samreen Ahmed, Simak Ali, Susan Cleator, Laura Kenny, Justin Stebbing, Mark J. Rutherford, Himanshu Sethi, Anna Boydell, Ryan Swenerton, Daniel Fernández-García, Kelly Gleason, Katie Goddard, David S. Guttery, Zoe J. Assaf, Hsin-Ta Wu, Prashanthi Natarajan, David A. Moore, Lindsay Primrose, Scott Dashner, Antony Tin, Mustafa Balcioglu, Ramya Srinivasan, Svetlana Shchegrova, Alexander Olson, Dina Hafez, Paul R. Billings, Alexey Aleshin, Farah Rehman, Bradley Toghill, Allison Hills, Maggie C. Louie, Cheng-Ho Jimmy Lin, Bernhard Zimmermann, Jacqui Shaw - Clinical Cancer Research 2019 cited by 512

  3. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

    Authors: Peter J. Richardson, Ivan Griffin, Catherine Tucker, D. Casey Smith, Olly Oechsle, Anne M. Phelan, Michael J. Rawling, Edward Savory, Justin Stebbing - The Lancet 2020 cited by 1,491

  4. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

    Authors: François‐Clément Bidard, Dieter Peeters, Tanja Fehm, Franco Nolè, Rafael Gisbert‐Criado, Dimitriοs Mavroudis, Salvatore Grisanti, Daniele Generali, José Á. García-Sáenz, Justin Stebbing, Carlos Caldas, Paola Gazzaniga, Luís Manso, Rita Zamarchi, Ángela Fernández de Lascoiti, Leticia De Mattos‐Arruda, Michail Ignatiadis, Ronald Lebofsky, Steven Van Laere, F Meier-Stiegen, Maria Teresa Sandri, José Vidal-Martínez, Eleni Politaki, Francesca Consoli, Alberto Bottini, Eduardo Díaz‐Rubio, Jonathan Krell, Sarah‐Jane Dawson, Cristina Raimondi, Annemie Rutten, Wolfgang Janni, Elisabetta Munzone, Vicente Carañana, Sofia Agelaki, Camillo Almici, Luc Dirix, Erich‐Franz Solomayer, Laura Zorzino, Helene Johannes, Jorge S. Reis‐Filho, Klaus Pantel, Jean‐Yves Pierga, Stefan Michiels - The Lancet Oncology 2014 cited by 838

  5. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

    Authors: François‐Clément Bidard, Stefan Michiels, Sabine Riethdorf, Volkmar Müller, Laura J. Esserman, Anthony Lucci, Bjørn Naume, Jun Horiguchi, Rafael Gisbert‐Criado, Stefan Sleijfer, Masakazu Toi, José Á. García-Sáenz, Andreas D. Hartkopf, Daniele Generali, Françoise Rothé, Jeffrey B. Smerage, Laura Muinelo‐Romay, Justin Stebbing, Patrice Viens, Mark Jesus M. Magbanua, Carolyn Hall, Olav Engebraaten, Daisuke Takata, José Vidal-Martínez, Wendy Onstenk, Noriyoshi Fujisawa, Eduardo Díaz‐Rubio, Florin‐Andrei Taran, Maria Rosa Cappelletti, Michail Ignatiadis, Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel - JNCI Journal of the National Cancer Institute 2018 cited by 282

  6. Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial

    Authors: Andrea J. Bullock, Benjamin L. Schlechter, Marwan Fakih, Apostolia M. Tsimberidou, Joseph E. Grossman, Michael S. Gordon, Breelyn A. Wilky, Agustin Pimentel, Daruka Mahadevan, Ani Sarkis Balmanoukian, Rachel E. Sanborn, Gary K. Schwartz, Ghassan K. Abou‐Alfa, Neil H Segal, Bruno Bockorny, Justin C. Moser, Sunil Sharma, Jaymin Patel, Wei Wu, Dhan Chand, Katherine Rosenthal, Gabriel Mednick, Chloé Delépine, Tyler J. Curiel, Justin Stebbing, Heinz‐Josef Lenz, Steven O’Day, Anthony B. El-Khoueiry - Nature Medicine 2024 cited by 110

  7. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

    Authors: Massimo Cristofanilli, Jean‐Yves Pierga, James M. Reuben, Alfred Rademaker, Andrew A. Davis, Dieter Peeters, Tanja Fehm, Franco Nolè, Rafael Gisbert‐Criado, Dimitriοs Mavroudis, Salvatore Grisanti, Mario Giuliano, José Á. García-Sáenz, Justin Stebbing, Carlos Caldas, Paola Gazzaniga, Luís Manso, Rita Zamarchi, Ángela Fernández de Lascoiti, Leticia De Mattos‐Arruda, Michail Ignatiadis, Luc Cabel, Steven Van Laere, F Meier-Stiegen, Maria Teresa Sandri, José Vidal-Martínez, Eleni Politaki, Francesca Consoli, Daniele Generali, Maria Rosa Cappelletti, Eduardo Díaz‐Rubio, Jonathan Krell, Sarah‐Jane Dawson, Cristina Raimondi, Annemie Rutten, Wolfgang Janni, Elisabetta Munzone, Vicente Carañana, Sofia Agelaki, Camillo Almici, Luc Dirix, Erich‐Franz Solomayer, Laura Zorzino, Lauren Darrigues, Jorge S. Reis‐Filho, Lorenzo Gerratana, Stefan Michiels, François‐Clément Bidard, Klaus Pantel - Critical Reviews in Oncology/Hematology 2018 cited by 268

  8. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors

    Authors: Eugene Izumchenko, K. Paz, Daniel Ciznadija, Ido Sloma, Amanda Katz, David Vasquez-Dunddel, Ido Ben-Zvi, Justin Stebbing, William P. McGuire, William Proctor Harris, Robert G. Maki, Andrew Gaya, A Bedi, Stergios Zacharoulis, Rajani Ravi, Leonard H. Wexler, Mohammad Obaidul Hoque, Carlos Rodríguez‐Galindo, Harvey I. Pass, Nir Peled, Angela M. Davies, Ronnie Morris, Manuel Hidalgo, D. Sidransky - Annals of Oncology 2017 cited by 337

  9. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

    Authors: David J. Pinato, Rohini Sharma, Elias Allara, Clarence Yen, Tadaaki Arizumi, Keiichi Kubota, Dominik Bettinger, Jeong Won Jang, Carlo Smirne, Young Woon Kim, Masatoshi Kudo, Jessica Howell, Ramya Ramaswami, Michela Emma Burlone, Vito Guerra, Robert Thimme, Mitsuru Ishizuka, Justin Stebbing, Mario Pirisi, Brian I. Carr - Journal of Hepatology 2016 cited by 417

  10. Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer

    Authors: Jacqui Shaw, Karen Page, Evie Wren, Elza C. de Bruin, Ekaterina Kalashnikova, Robert Hastings, Rob McEwen, Eddie Zhang, Marc Wadsley, Emmanuel Acheampong, Derrick Renner, Kelly Gleason, Bana Ambasager, Daniel Stetson, Daniel Fernández-García, David S. Guttery, Rebecca C. Allsopp, Angel Rodriguez, Bernhard Zimmermann, Himanshu Sethi, Alexey Aleshin, Minetta C. Liu, Cathy Richards, Justin Stebbing, Simak Ali, Farah Rehman, Susan Cleator, Laura Kenny, Samreen Ahmed, Anne Armstrong, R. Charles Coombes - JCO Precision Oncology 2024 cited by 47

  11. Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients

    Authors: Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J. Richardson, Vanessa Monteil, Volker M. Lauschke, Alì Mirazimi, Sonia Youhanna, Yee‐Joo Tan, Fausto Baldanti, Antonella Sarasini, Jorge Alfonso Ross Terres, Brian J. Nickoloff, Richard E. Higgs, Guilherme Rocha, Nicole L Byers, Douglas Schlichting, Ajay Nirula, Anabela Cardoso, Mario Corbellino, the Sacco Baricitinib Study Group - EMBO Molecular Medicine 2020 cited by 272

  12. A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond

    Authors: Shiran Shapira, Marina Ben Shimon, Mori Hay‐Levi, Gil Shenberg, Guy Choshen, Lian Bannon, Michael Tepper, Dina Kazanov, Jonathan Seni, Shahar Lev‐Ari, Michael Peer, Dimitrios Boubas, Justin Stebbing, Sotirios Tsiodras, Nadir Arber - EMBO Molecular Medicine 2022 cited by 62

  13. Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy

    Authors: Mark Jesus M. Magbanua, Laura H. Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford A. Hudis, Deborah Toppmeyer, Lisa A. Carey, Ann H. Partridge, Jean‐Yves Pierga, Tanja Fehm, José Vidal-Martínez, Dimitriοs Mavroudis, José Á. García-Sáenz, Justin Stebbing, Paola Gazzaniga, Luís Manso, Rita Zamarchi, María Luisa Antelo, Leticia De Mattos‐Arruda, Daniele Generali, Carlos Caldas, Elisabetta Munzone, Luc Dirix, Amy L. Delson, Harold J. Burstein, Misbah Qadir, X. Cynthia, Janet H. Scott, François‐Clément Bidard, John W. Park, Hope S. Rugo - JNCI Journal of the National Cancer Institute 2020 cited by 48

  14. A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers

    Authors: Ling Peng, Jisheng Li, Jie Wu, Bin Xu, Zhiqiang Wang, Georgios Giamas, Justin Stebbing, Zhentao Yu - Frontiers in Immunology 2021 cited by 93

  15. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression

    Authors: Silvia Ottaviani, Justin Stebbing, Adam E. Frampton, Sladjana Zagorac, Jonathan Krell, Alexander de Giorgio, Sara Maria David Trabulo, Van T.M. Nguyen, Luca Magnani, Hugang Feng, Elisa Giovannetti, Niccola Funel, Thomas M. Gress, Long R. Jiao, Ylenia Lombardo, Nicholas R. Lemoine, Christopher Heeschen, Leandro Castellano - Nature Communications 2018 cited by 137

  16. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib

    Authors: Ling Peng, Kui Xiao, Silvia Ottaviani, Justin Stebbing, Ying-Jie Wang - Expert Opinion on Drug Safety 2020 cited by 81

  17. Targeting ALK Rearrangements in NSCLC: Current State of the Art

    Authors: Ling Peng, Liping Zhu, Yilan Sun, Justin Stebbing, Giovanni Selvaggi, Yongchang Zhang, Zhentao Yu - Frontiers in Oncology 2022 cited by 60

  18. PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38MAPK signalling

    Authors: Rosemary Lane, Chiara Cilibrasi, Jianing Chen, Kalpit Shah, Eleonora Messuti, Nektarios K. Mazarakis, Justin Stebbing, Giles Critchley, Erwei Song, Thomas R. Simon, Georgios Giamas - Oncogene 2022 cited by 47

  19. Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy

    Authors: Aradhana Rani, Justin Stebbing, Georgios Giamas, John J. Murphy - Frontiers in Endocrinology 2019 cited by 232

  20. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden

    Authors: Adam E. Frampton, Mireia Mato Prado, Elena López‐Jiménez, Ana Belen Fajardo-Puerta, Zaynab Jawad, Phillip Lawton, Elisa Giovannetti, Nagy Habib, Leandro Castellano, Justin Stebbing, Jonathan Krell, Long R. Jiao - Oncotarget 2018 cited by 162

  21. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

    Authors: Antonino Glaviano, Seth A. Wander, Richard D. Baird, Kenneth Chun-Yong Yap, Hiu Yan Lam, Masakazu Toi, Daniela Carbone, Birgit Geoerger, Violeta Serra, Robert H. Jones, Joanne Ngeow, Eneda Toska, Justin Stebbing, Karen Crasta, Richard S. Finn, Patrizia Diana, Karla Vuina, Robertus A.M. de Bruin, Uttam Surana, Aditya Bardia, Alan Prem Kumar - Drug Resistance Updates 2024 cited by 58

  22. A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome

    Authors: Terese Hammond, Marco A. Purbhoo, Sapana Kadel, Jerome Ritz, Sarah Nikiforow, Heather Daley, Kit L. Shaw, Koen van Besien, Alexandra Gomez-Arteaga, Don A. Stevens, Waldo Ortuzar, Xavier Michelet, Rachel A. Smith, Darrian Moskowitz, Reed Masakayan, Burcu Yigit, Shannon K. Boi, Kah Teong Soh, John P. Chamberland, Xin Song, Yu Q, I. V. Mishchenko, M. W. Kirby, Valeriia Nasonenko, Alexa Buffa, Jennifer S. Buell, Dhan Chand, Marc Van Dijk, Justin Stebbing, Mark A. Exley - Nature Communications 2024 cited by 38

  23. Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer

    Authors: Alison Harrod, J Fulton, Van T.M. Nguyen, Manikandan Periyasamy, L Ramos-Garcia, C-F Lai, Gergana Metodieva, Alex de Giorgio, RANDALL WILLIAMS, Daniela Barsotti Santos, Pedro José Prada Gómez, M-L Lin, Metodi V. Metodiev, Justin Stebbing, Leandro Castellano, Luca Magnani, R. Charles Coombes, Laki Buluwela, Simak Ali - Oncogene 2016 cited by 180

  24. Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping

    Authors: Rosemary Lane, Thomas R. Simon, Marian Vintu, Benjamin Solkin, Barbara Koch, Nicolas A. Stewart, Graeme Benstead-Hume, Frances M. G. Pearl, Giles Critchley, Justin Stebbing, Georgios Giamas - Communications Biology 2019 cited by 101